No Data
No Data
Lancy co.,ltd. (002612.SZ): The subsidiary plans to increase capital by 0.95 billion yuan for Peking Lancy Medical Management.
On November 28, Glonghui announced that lancy co.,ltd. (002612.SZ) had revealed that its wholly-owned subsidiary, lancy medical management co.,ltd. (referred to as 'lancy medical management', which holds 100% of the equity of peking lancy medical management), plans to increase its capital in peking lancy medical management by 0.95 billion yuan in cash. After this capital increase is completed, the paid-in capital of peking lancy medical management will rise from the original 50 million yuan to 1 billion yuan, and peking lancy medical management will remain a wholly-owned subsidiary of lancy medical management.
Lancy Co., Ltd. (002612.SZ): As of the end of the third quarter this year, the company already owns 41 medical beauty institutions.
GrainSight on November 28th | Lancy Co., Ltd. (002612.SZ) stated on the investor interaction platform that as of the end of the third quarter of this year, the company already owns 41 medical beauty institutions, including: 11 comprehensive hospitals; 30 clinics and outpatient departments. Since the beginning of this year, by acquiring the target held by the Medical Beauty Industry Fund's out-of-hospital, 3 comprehensive medical beauty hospitals have been added. In addition, Lancy Co., Ltd. has deployed 5 life beauty institutions under the sub-brand "CrystalSkin Beauty Centre" around the community-oriented and lifestyle-oriented business development strategy. In the first three quarters of this year, the medical beauty business sector achieved revenue of approximately 2.071 billion yuan.
Guosen: The wave of mergers and acquisitions in the retail industry is rising, an important growth paradigm for enterprises in the era of existing inventory.
From the perspective of leading listed companies, a significant amount of capital operation and diversified management experience has been accumulated in recent years. With the increasing demand for exits in the primary market, many high-quality consumer symbols have also provided listed companies with good acquisition and integration opportunities.
Lancy Co.,Ltd. (002612.SZ): So-Young International is currently one of the company's supply chain partners.
On November 22, Grinnell Holdings stated on the investor interaction platform that ReNature Oriental Structural Aesthetics is an aesthetic injection design system proposed by Lancy Co.,Ltd.'s medical aesthetics based on the commonalities of Eastern facial structure and contemporary aesthetics. The ReNature project is developed by Lancy Co.,Ltd.'s medical aesthetics, and the materials used come from the company's normal procurement business. After inquiries and confirmation with the person in charge of the company's medical aesthetics supply chain, So-Young International is currently one of the company's supply chain partners. In addition, the company has not signed any other strategic cooperation agreements with So-Young International.
lancy co.,ltd. (002612.SZ): There is currently no plan to open franchise.
Gelonghui Nov. 22nd | Lancy Co.,Ltd. (002612.SZ) stated on the investor interaction platform that currently, all 30 Jinfu brand chain institutions of Lancy are operated as direct medical institutions in multiple cities. The safety and quality control of light medical beauty is crucial. We are continuously improving and enhancing the chain operation control system and technical service capabilities, with no current plans to open for franchise.
lancy co.,ltd. (002612.SZ): Appointed Hou Licheng as the company's Chief Financial Officer.
Gelonghui November 11th | Lancy Co., Ltd. (002612.SZ) announced that the board of directors recently received Ms. Chang Jing's written resignation. Due to work adjustment reasons, Ms. Chang Jing resigned from the position of the company's Chief Financial Officer. After resigning as the company's Chief Financial Officer, Ms. Chang Jing will continue to serve as the company's Deputy General Manager, and the daily operation and related work of the company will not be affected. In accordance with the nomination of Ms. Shen Jinhua, the company's General Manager, and with the agreement of all members of the nomination committee and the audit committee, the board of directors agreed to appoint Mr. Hou Licheng as the company's Chief Financial Officer, with a term from the date of approval by this board meeting until the end of the fifth session of the board of directors.
No Data
No Data